Product Information
ELESTRIN 0.06% GEL is a brand product labeled by Viatris Specialty LLC, priced at $3.6093 per GM under NDC 00037480170. Its NADAC has been published 394 times since Mar 20, 2019.
FDA first approved this application on Dec 15, 2006.
Strength
.52 mg/.87g
Manufacturer
Viatris Specialty LLCNDC
00037480170
Classification
Brand
Dosage Form
GEL, METERED
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
ESTRADIOLApproval Type
New Drug (NDA)
FDA Application
NDA021813FDA Approved
12/15/2006
On Market Since
6/2/2014
Pharmacological Classes
Price Statistics
The NADAC for ELESTRIN 0.06% GEL has been published 394 times since Mar 20, 2019, and over the history we have for it it has risen 29.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.6093 per GM |
|---|---|
| All-time high | $3.6120 (Jul 15, 2026) |
| All-time low | $2.7521 (Dec 18, 2019) |
| 52-week high | $3.6120 |
| 52-week low | $3.5738 |
| Median price | $3.2516 |
| Average price | $3.2715 |
| Largest weekly change | +7.0% (Jan 11, 2023) |
| Weeks tracked | 394 |
| Tracking since | Mar 20, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ESTRADIOL market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viatris Specialty LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ESTRADIOL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ELESTRIN 0.06% GEL?
The current National Average Drug Acquisition Cost (NADAC) for ELESTRIN 0.06% GEL, manufactured by Viatris Specialty LLC, is $3.6093 per GM (NDC 00037480170), effective Sep 30, 2026.
How has the price of ELESTRIN 0.06% GEL changed over time?
Over the history we have for it, the NADAC for ELESTRIN 0.06% GEL has risen 29.9%. It has been tracked across 394 weekly CMS publications since Mar 20, 2019.
What are the highest and lowest recorded NADAC prices for ELESTRIN 0.06% GEL?
Since Mar 20, 2019, the NADAC for ELESTRIN 0.06% GEL has ranged from a low of $2.7521 (Dec 18, 2019) to a high of $3.6120 (Jul 15, 2026), with a median of $3.2516 per GM.
Are there cheaper alternatives to ELESTRIN 0.06% GEL?
No other NADAC-published product currently shares the active ingredient and strength of ELESTRIN 0.06% GEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ELESTRIN 0.06% GEL?
ELESTRIN 0.06% GEL (NDC 00037480170) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.